Literature DB >> 17490870

The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.

Kumi Tanaka1, Yasuyuki Yokosaki, Fumiko Higashikawa, Yuji Saito, Akira Eboshida, Mitsuo Ochi.   

Abstract

Soluble GTP-bound transglutaminase 2 (TG2) induces hypertrophic differentiation in chondrocyte cultures in a beta1 integrin-dependent fashion. beta1 integrin subfamily consists of 12 heterodimers with 12 different alpha subunits and a beta1 subunit. To identify the specific integrin heterodimer(s) responsible for this process, we specifically blocked individual beta1 integrins on the CH-8 immortalized human chondrocytes during hypertrophic differentiation. Blockade of alpha5beta1 inhibited matrix metalloproteinase 13 (MMP-13), type X collagen expression, alkaline phosphatase activity and matrix calcification by 30-50% associated with weak effects of anti-alpha3beta1 and -alpha4beta1. Anti-alpha1beta1, -alpha2beta1 and -alpha6beta1 had no effect. To examine whether the dominant effect of integrin alpha5beta1 was due to a direct interaction with TG2, we incubated the chondrocytic cells on plates coated with GTP-bound TG2. The immobilized GTP-bound TG2 induced hypertrophic differentiation to the same extent as the soluble GTP-bound TG2, which was also inhibited by anti-alpha5beta1. CH-8 cells grown on plates coated with GTP-bound TG2 demonstrated adherence associated with focal adhesion kinase phosphorylation. These properties were inhibited by anti-alpha5beta1. Furthermore, engagement of alpha5beta1 on CH-8 cells via anti-alpha5beta1 antibody did, in fact, induce differentiation. Although CH-8 cells adhered to GTP-free TG2 via integrin alpha5beta1, the cells failed to undergo hypertrophic differentiation. Thus, integrin alpha5beta1 is critical for the chondrocyte hypertrophic differentiation induced by GTP-bound TG2, and this induction is ligand dependent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490870     DOI: 10.1016/j.matbio.2007.04.005

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  8 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

3.  Tissue-specific responses to loss of transglutaminase 2.

Authors:  Stephanie Deasey; Shobana Shanmugasundaram; Maria Nurminskaya
Journal:  Amino Acids       Date:  2011-12-23       Impact factor: 3.520

4.  rFN/Cad-11-modified collagen type II biomimetic interface promotes the adhesion and chondrogenic differentiation of mesenchymal stem cells.

Authors:  Shiwu Dong; Hongfeng Guo; Yuan Zhang; Zhengsheng Li; Fei Kang; Bo Yang; Xia Kang; Can Wen; Yanfei Yan; Bo Jiang; Yujiang Fan
Journal:  Tissue Eng Part A       Date:  2013-08-06       Impact factor: 3.845

5.  Beta1 integrin deficiency results in multiple abnormalities of the knee joint.

Authors:  Aurelia Raducanu; Ernst B Hunziker; Inga Drosse; Attila Aszódi
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

6.  Regulation of α5 and αV Integrin Expression by GDF-5 and BMP-7 in Chondrocyte Differentiation and Osteoarthritis.

Authors:  David Garciadiego-Cázares; Hilda I Aguirre-Sánchez; René F Abarca-Buis; Juan B Kouri; Cristina Velasquillo; Clemente Ibarra
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Strategies to minimize hypertrophy in cartilage engineering and regeneration.

Authors:  Song Chen; Peiliang Fu; Ruijun Cong; HaiShan Wu; Ming Pei
Journal:  Genes Dis       Date:  2015-03-01

Review 8.  Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.

Authors:  M Adamczyk
Journal:  Amino Acids       Date:  2016-08-10       Impact factor: 3.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.